Harpoon Therapeutics
IPO News: Filed S-1/A: Harpoon Therapeutics Launches 5.4mm Share IPO with $13.00 - $15.00 Marketing Range
Harpoon Therapeutics


Initial Filing Date: 12/28/19

Launch Date:      01/29/19            

Price Range: $13.00 - $15.00

Initial Shares Offered (mm): 5.4

Shares Offered (Pre-Shoe | mm): 5.4

Primary Shares (mm):      5.4

Secondary Shares (mm): 0.0

Amount Offered (@ Midpoint)(mm): $75.6

% Secondary: 0.0%

Shares Outstanding (mm): 23.9

Market Value at Midpoint (mm): $334.7

Offering as % of Market Value:    22.6%

Bookrunners:      CITI | LEER

Co-Managers:  CANA | WED

Major Holders: MPM Capital | UBS Oncology Impact Fund | New Leaf Ventures | Arix Bioscience | OrbiMed

Industry: Healthcare

Description: Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases

Note: Emerging Growth Company            

Launch Link: S-1/A